Primatene Tablet
NDC Package 80070-600-60
Package Information
Primatene (ephedrine hydrochloride) tablets is do not take more than directedadults and children 12 years and over: take 1-2 tablets every 4 hours as needed. This formulation utilizes a tablet delivery system. Marketed by Foundation Consumer Brands, this product is identified by NDC 80070-600 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 2534871 - ePHEDrine HCl 12.5 MG Oral Tablet
- RxCUI: 2534871 - ephedrine hydrochloride 12.5 MG Oral Tablet
- RxCUI: 2534871 - ephedrine HCl 12.5 MG Oral Tablet
- RxCUI: 2591390 - Primatene with ePHEDrine 12.5 MG Oral Tablet
- RxCUI: 2591390 - ephedrine hydrochloride 12.5 MG Oral Tablet [Primatene with ephedrine]
Clinical Specifications
- Adrenergic alpha-Agonists - [MoA] (Mechanism of Action)
- Adrenergic beta-Agonists - [MoA] (Mechanism of Action)
- Increased Norepinephrine Activity - [PE] (Physiologic Effect)
- Norepinephrine Releasing Agent - [EPC] (Established Pharmacologic Class)
- alpha-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
- beta-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 80070 - Foundation Consumer Brands
- 80070-600 - Primatene
- 80070-600-60 - 5 BLISTER PACK in 1 CARTON / 12 TABLET in 1 BLISTER PACK
- 80070-600 - Primatene
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (80070-600). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 80070-600-60 identifies a specific commercial package of 5 blister pack in 1 carton / 12 tablet in 1 blister pack of Primatene, a human over the counter drug labeled by Foundation Consumer Brands. This tablet is formulated for oral use and contains ephedrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Foundation Consumer Brands on January 22, 2021. The current certification is valid through December 31, 2026.
How is this Foundation Consumer Brands product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 80070060060. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.